4//SEC Filing
Ni Fang 4
Accession 0001415889-22-001513
CIK 0001701541other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:15 PM ET
Size
5.6 KB
Accession
0001415889-22-001513
Insider Transaction Report
Form 4
Ni Fang
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+100,000→ 100,000 totalExercise: $3.79Exp: 2032-02-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001895910
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:15 PM ET
- Size
- 5.6 KB